Search Ontology:
ChEBI

alpha-L-Fucp-(1->4)-[beta-D-Galp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp

Term ID
CHEBI:61334
Synonyms
  • (Gal)2 (Glc)1 (GlcNAc)1 (LFuc)1
  • 6-deoxy-alpha-L-galactopyranosyl-(1->4)-[beta-D-galactopyranosyl-(1->3)]-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose
  • alpha-Fuc-(1->4)-[beta-Gal-(1->3)]-beta-GlcNAc-(1->3)-beta-Gal-(1->4)-Glc
  • alpha-L-Fuc-(1->4)-[beta-D-Gal-(1->3)]-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc
  • alpha-L-fucopyranosyl-(1->4)-[beta-D-galactopyranosyl-(1->3)]-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose
  • alpha-L-fucosyl-(1->4)-[beta-D-galactosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-D-glucose
  • beta-D-Gal-(1->3)-(alpha-L-Fuc-(1->4))-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc
  • Fucalpha1->4(Galbeta1->3)GlcNAcbeta1->3Galbeta1->4Glc
  • Galbeta1->3(Fucalpha1->4)GlcNAcbeta1->3Galbeta1->4Glc
  • Lacto-N-fucopentaitol II
  • Lacto-N-fucopentaose II
  • Lewis a
  • Lewis a pentasaccharide
  • LNF-II
Definition
A branched amino pentasaccharide comprising one fucose, two galactose, one glucosamine and one glucose unit (at the reducing end), linked as shown.
References
  • glygen:G98173LG
  • glytoucan:G98173LG
  • kegg.glycan:G00623
  • pubmed:11425797
  • pubmed:12354382
  • pubmed:2171767
  • pubmed:2776132
  • pubmed:3274083
  • pubmed:7574700
  • pubmed:8675304
  • pubmed:9271064
  • reaxys:6050703
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from alpha-L-Fucp-(1->4)-[beta-D-Galp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp
Phenotype where environments contain alpha-L-Fucp-(1->4)-[beta-D-Galp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp
Phenotype modified by environments containing alpha-L-Fucp-(1->4)-[beta-D-Galp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp
Phenotype affecting alpha-L-Fucp-(1->4)-[beta-D-Galp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp
Human Disease Model